The-Powerful-Omega-3-Fatty-Acids

The Powerful Omega-3 Fatty Acids

Did you know?

Omega-3 Fatty Acids & Blood Pressure1

  • Intake of Omega-3 fatty acids for Blood Pressure lowering is between 2,000mg/d and 3,000mg/d.
  • Doses of Omega-3 fatty acids > 3,000mg/d may be associated with lowering Blood Pressure among cardiovascular diseases patients.
  • Intake of Omega-3 fatty acids could be beneficial for controlling Blood Pressure even before the onset of
    hypertension.

Omega-3 Fatty Acids & Coronary Heart Diseases Risks2

  • 800mg – 1200mg Omega-3 fatty acids alleviated cardiovascular disease risk.
  • Omega-3 fatty acids had a positive effect in reducing the incidence of major adverse cardiovascular events.
  • Omega-3 fatty acids can prevent the occurrence of myocardial infarction.

Polyunsaturated fatty acids against Covid-193

  • Omega-3 fatty acids found to be 12-22% effective in reducing the risk of Covid-19.
  • Lack of omega-3 fatty acids increasing mortality, severity and the need for mechanical ventilation and hospitalization.
  • Omega-3 fatty acids effective in lowering the impact of inflammation produced by Covid-19.
  • Mortality rate of patients with Covid-19 increased to 3 times in patients with low omega-3 fatty acids levels.

Ormega - High Potency & Purity Fish Oil

Elken Ormega are using most advance technology called Heat-free Supercritical CO2 and with this technology, Elken Ormega can produce fish oil with high concentration and strength of Omega-3 fatty acids.

Parameter Elken Ormega
Fish Oil Content 1,200mg
EPA/DHA Content (Omega-3 fatty acids) 600mg / 300mg (Total 900mg)
Concentration EPA DHA 75%
EPA DHA Ratiov (Golden ratio with high efficacy on anti-inflammatory effects.) 2:1
Recomended Dosage (Health Maintenance) softgel/day
Recommended Dosage (Illness) 2 softgels/day
Sources:
  1. Xin Zhang.et al. (2022). Omega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc, 11(11), e025071.
  2. ShiChun Shen. et al. (2022). Omega-3 Fatty Acid Supplementation and Coronary Heart Disease Risks: A Meta-Analysis of Randomized Controlled Clinical Trials. Front Nutr, 9, 809311.
  3. Afrooz Mazidimoradi. et al. (2022). The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review. Life Sci, 299, 120489.

Comments are closed.